首页> 外文期刊>Research journal of microbiology. >Antifungal Activity and the Potential Correlation with Statin-Producing Ability: An Optimized Screening Applied to Filamentous Fungi from Las Yungas Subtropical Rainforest
【24h】

Antifungal Activity and the Potential Correlation with Statin-Producing Ability: An Optimized Screening Applied to Filamentous Fungi from Las Yungas Subtropical Rainforest

机译:抗真菌活性及其与抑菌素生产能力的潜在相关性:一种优化的筛选方法,应用于拉斯加加斯亚热带雨林的丝状真菌

获取原文
获取原文并翻译 | 示例
       

摘要

Research was aimed at investigating statin-related antifungal activity of fungal specimens isolated from Las Yungas Pedemontana Forest. Considering the participation of statins as a potential mechanism for competition in natural environments, their production was particularly analyzed. Following the 'dereplication' concept for identifying natural products, extracts from fungal isolates were screened by yeast-growth inhibition bioassays, TLC and RP-HPLC analysis. Extraction from fungal cultures was performed according to three alternative protocols: glass-beads, Waring blender disruption, or a freeze-thawing method. Waring-blender-obtained fungal extracts led to higher yields of potentially statin-related compounds than those of glass-beads disruption or freeze-thawing. Around a 10% of 201 Las Yungas isolates showed statin-compatible TLC(+) profiles, thus being pre-selected as potential statin-producers. During yeast bioassays, 13 extracts inhibited S. cerevisiae ATCC 32051 growth whilst seven had the same effect on Candida utilis Pr_1-2. Some peaks revealed by RP-HPLC corresponded to known statins like pravastatin, lovastatin and simvastatin. Statin-producing isolates were identified as Hypocrea and Penicillium genera members. Despite the low statin titres (~3 mg L~-1), likely related to non-optimal production conditions, some fungal extracts were able to inhibit HMGCoA-reductase between 1.3 and 18.6%. Antifungal activities of selected isolates could be thus related to statin production, probably as a competition skill in natural ecosystems. This report highlights the hidden biotechnological potential, such as statin production ability, of indigenous filamentous fungi from subtropical rainforests of Las Yungas. Additionally, optimized protocols for statin-production assessment are herein proposed for future screening programs.
机译:这项研究的目的是调查从拉斯·云加斯·佩德蒙塔那森林(Las Yungas Pedemontana Forest)分离的真菌标本与他汀类药物相关的抗真菌活性。考虑到他汀类药物的参与是自然环境中竞争的潜在机制,因此对他汀类药物的生产进行了特别分析。遵循用于鉴定天然产物的“重复”概念,通过酵母生长抑制生物测定,TLC和RP-HPLC分析筛选真菌分离物中的提取物。根据三种替代方案从真菌培养物中提取:玻璃珠,沃林氏搅拌器破碎法或冻融法。 Waring-blender获得的真菌提取物导致潜在的他汀类药物相关化合物的产量高于玻璃珠破坏或冻融的产量。 201个Las Yungas分离株中约有10%显示出他汀类药物相容的TLC(+)谱,因此被预选为潜在的他汀类药物生产者。在酵母生物测定过程中,有13种提取物抑制了酿酒酵母ATCC 32051的生长,而有7种提取物对on假丝酵母Pr_1-2具有相同的作用。 RP-HPLC揭示的一些峰对应于已知的他汀类药物,如普伐他汀,洛伐他汀和辛伐他汀。产生他汀的分离株被鉴定为hypocrea和青霉属成员。尽管他汀类药物滴度较低(〜3 mg L〜-1),可能与非最佳生产条件有关,但某些真菌提取物仍能抑制HMGCoA还原酶在1.3%至18.6%之间。因此,某些分离株的抗真菌活性可能与他汀类药物的生产有关,可能是自然生态系统中的一种竞争技能。该报告强调了来自拉斯云加斯亚热带雨林的本土丝状真菌的潜在生物技术潜力,例如他汀类药物的生产能力。另外,本文提出了用于他汀类药物生产评估的优化方案,以用于将来的筛选程序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号